Fisher SA - Search Results

1

Tumor Infiltrating Effector Memory Antigen-Specific CD8⁺ T Cells Predict Response to Immune Checkpoint Therapy.

Principe N, Kidman J, Goh S, Tilsed CM, Fisher SA, Fear VS, Forbes CA, Zemek RM, Chopra A, Watson M, Dick IM, Boon L, Holt RA, Lake RA, Nowak AK, Lesterhuis WJ, McDonnell AM, Chee J. Principe N, et al. Among authors: fisher sa. Front Immunol. 2020 Nov 12;11:584423. doi: 10.3389/fimmu.2020.584423. eCollection 2020. Front Immunol. 2020. PMID: 33262762 Free PMC article.

2

Lack of ignorance to tumor antigens: evaluation using nominal antigen transfection and T-cell receptor transgenic lymphocytes in Lyons-Parish analysis--implications for tumor tolerance.

Robinson BW, Scott BM, Lake RA, Stumbles PA, Nelson DJ, Fisher S, Marzo AL. Robinson BW, et al. Clin Cancer Res. 2001 Mar;7(3 Suppl):811s-817s. Clin Cancer Res. 2001. PMID: 11300477

3

Tumor progression despite efficient tumor antigen cross-presentation and effective "arming" of tumor antigen-specific CTL.

Nelson DJ, Mukherjee S, Bundell C, Fisher S, van Hagen D, Robinson B. Nelson DJ, et al. J Immunol. 2001 May 1;166(9):5557-66. doi: 10.4049/jimmunol.166.9.5557. J Immunol. 2001. PMID: 11313395

4

Interferon-gamma response by peripheral blood mononuclear cells to hepatitis C virus core antigen is reduced in patients with liver fibrosis.

Watson MW, Jaksic A, Price P, Cheng W, McInerney M, French MA, Fisher S, Lee S, Flexman JP. Watson MW, et al. J Infect Dis. 2003 Nov 15;188(10):1533-6. doi: 10.1086/379252. Epub 2003 Nov 4. J Infect Dis. 2003. PMID: 14624379

5

Quantitation of defective and ecotropic viruses during LP-BM5 infection by real time PCR and RT-PCR.

Paun A, Shaw K, Fisher S, Sammels LM, Watson MW, Beilharz MW. Paun A, et al. J Virol Methods. 2005 Mar;124(1-2):57-63. doi: 10.1016/j.jviromet.2004.11.001. Epub 2004 Dec 16. J Virol Methods. 2005. PMID: 15664051

6

The "Trojan Horse" approach to tumor immunotherapy: targeting the tumor microenvironment.

Nelson D, Fisher S, Robinson B. Nelson D, et al. J Immunol Res. 2014;2014:789069. doi: 10.1155/2014/789069. Epub 2014 May 18. J Immunol Res. 2014. PMID: 24955376 Free PMC article. Review.

7

Neoadjuvant anti-tumor vaccination prior to surgery enhances survival.

Fisher SA, Cleaver A, Lakhiani DD, Khong A, Connor T, Wylie B, Lesterhuis WJ, Robinson BW, Lake RA. Fisher SA, et al. J Transl Med. 2014 Sep 4;12:245. doi: 10.1186/s12967-014-0245-7. J Transl Med. 2014. PMID: 25186961 Free PMC article.

8

Chemotherapy enhances cross-presentation of nuclear tumor antigens.

Anyaegbu CC, Lake RA, Heel K, Robinson BW, Fisher SA. Anyaegbu CC, et al. Among authors: fisher sa. PLoS One. 2014 Sep 22;9(9):e107894. doi: 10.1371/journal.pone.0107894. eCollection 2014. PLoS One. 2014. PMID: 25243472 Free PMC article.

9

The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40.

Khong A, Cleaver AL, Fahmi Alatas M, Wylie BC, Connor T, Fisher SA, Broomfield S, Lesterhuis WJ, Currie AJ, Lake RA, Robinson BW. Khong A, et al. Among authors: fisher sa. BMC Cancer. 2014 Dec 17;14:969. doi: 10.1186/1471-2407-14-969. BMC Cancer. 2014. PMID: 25518732 Free PMC article.

10

Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen.

Creaney J, Ma S, Sneddon SA, Tourigny MR, Dick IM, Leon JS, Khong A, Fisher SA, Lake RA, Lesterhuis WJ, Nowak AK, Leary S, Watson MW, Robinson BW. Creaney J, et al. Among authors: fisher sa. Oncoimmunology. 2015 May 11;4(7):e1011492. doi: 10.1080/2162402X.2015.1011492. eCollection 2015 Jul. Oncoimmunology. 2015. PMID: 26140232 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters